Investor Presentation
25
Investor presentation First six months of 2022
Sales growth of 16%, driven by both NAO and IO with 24% and
10% sales growth respectively
Novo NordiskⓇ
Historic and reported sales by geography
Reported sales and growth breakdown
DKK
billion
for the first six months of 2022
Regions
111.6
140.8
83.3
Sales
(mDKK)
Growth
Share of
growth
13%
14%
15%
International Operations
42,603
10%
35%
10%
11%
10%
EMEA
21,739
12%
21%
26%
27%
26%
Region China
8,407
-5%
-4%
ROW
12,457
21%
19%
North America Operations
40693
24%
65%
52%
48%
49%
Hereof USA
37,874
23%
58%
Total sales
83,296
16%
100%
2017
2021
H1 2022
North America
EMEA
Region China
ROW
Source: Quarterly company announcement
IO: International Operations; NAO: North American Operations; EMEA: Europe, Middle East, and Africa; Row: Rest of World; Region China covers mainland China, Hong Kong and Taiwan.
Note: Numbers may not add up to 100% due to rounding; Growth at Constant exchange rates; Sales numbers are reported in Danish kronerView entire presentation